Qrons Inc is a biotechnology company developing advanced cell-based solutions to combat neuronal injuries with a laser focus on traumatic brain injuries. The technology would treat a wide range of neurodegenerative diseases. The treatment integrates proprietary, engineered mesenchymal stem cells, 3D printable scaffolding, smart materials, and a novel delivery system. The firm has two product candidates, QS100TM for treating penetrating brain injuries and QS200TM, for treating concussions and other diffused axonal injuries.
Quote | Qrons Inc (OTCMKTS:QRON)
Last: | $0.185475 |
---|---|
Change Percent: | 0.0% |
Open: | $0.185475 |
Close: | $0.185475 |
High: | $0.185475 |
Low: | $0.185475 |
Volume: | 1,000 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Qrons Inc (OTCMKTS:QRON)
NEW YORK, NY / ACCESSWIRE / November 20, 2023 / Qrons Inc. (OTCQB:QRON) announced that Professor Shiri Navon-Venezia has agreed to join Qrons Scientific Advisory Board. Professor Venezia is Professor of Microbiology, Head of Bacterial Pathogens & Antibiotic Resistance Lab in Ariel University...
NEW YORK, NY / ACCESSWIRE / August 23, 2023 / Qrons Inc. (OTCQB:QRON) an innovative biotechnology company dedicated to developing products treatments and technologies to combat neuronal and infectious diseases with a focus on antibiotic resistant bacteria, announced today the launch of its updat...
Message Board Posts | Qrons Inc (OTCMKTS:QRON)
Subject | By | Source | When |
---|---|---|---|
There is someone slowly buying a few hundred | Retire43 | investorshub | 01/12/2023 11:20:20 PM |
Getting some action on Qrons today! 12/14/22. New Pre-clinical | Retire43 | investorshub | 01/05/2023 6:50:43 PM |
We have had one trade per day for | Retire43 | investorshub | 09/22/2022 2:16:40 PM |
This is coming to life! | Retire43 | investorshub | 09/14/2021 4:53:50 PM |
Wow 2,276 @ .80 ! | Retire43 | investorshub | 09/14/2021 4:53:28 PM |
News, Short Squeeze, Breakout and More Instantly...
NEW YORK, NY / ACCESSWIRE / November 20, 2023 / Qrons Inc. (OTCQB:QRON) announced that Professor Shiri Navon-Venezia has agreed to join Qrons Scientific Advisory Board. Professor Venezia is Professor of Microbiology, Head of Bacterial Pathogens & Antibiotic Resistance Lab in Ariel University...
NEW YORK, NY / ACCESSWIRE / August 23, 2023 / Qrons Inc. (OTCQB:QRON) an innovative biotechnology company dedicated to developing products treatments and technologies to combat neuronal and infectious diseases with a focus on antibiotic resistant bacteria, announced today the launch of its updat...
NEW YORK, NY / ACCESSWIRE / August 14, 2023 / Qrons Inc. (OTCQB:QRON) an innovative biotechnology company dedicated to developing products to combat neuronal and infectious diseases with a focus on antibiotic resistant bacteria, announced today the filing on August 9, of a United States Provisio...